Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2014, Article ID 923593, 8 pages
http://dx.doi.org/10.1155/2014/923593
Review Article

Hypertransfusion Therapy in Sickle Cell Disease in Nigeria

Department of Haematology and Blood Transfusion, University of Benin Teaching Hospital, PMB 1111, Benin City, Edo State, Nigeria

Received 3 February 2014; Revised 18 June 2014; Accepted 17 July 2014; Published 7 August 2014

Academic Editor: Peter Bader

Copyright © 2014 Ademola Samson Adewoyin and Jude Chike Obieche. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Weatherall and J. B. Clegg, “Inherited haemoglobin disorders: an increasing global health problem,” Bulletin of the World Health Organization, vol. 79, no. 8, pp. 704–712, 2001. View at Google Scholar · View at Scopus
  2. B. Modell and M. Darlison, “Global epidemiology of haemoglobin disorders and derived service indicators,” Bulletin of the World Health Organization, vol. 86, no. 6, pp. 480–487, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. WHO Regional Office for Africa, “Sickle cell disease prevention and control,” November 2013, http://www.afro.who.int/en/nigeria/nigeria-publications/1775-sickle%20cell%20disease.html.
  4. G. R. Serjeant and B. E. Sergent, “The epidemiology of sickle cell disorder: a challenge for Africa,” Archives of Ibadan Medicine, vol. 2, no. 2, pp. 4–52, 2001. View at Google Scholar
  5. A. L. Okwi, W. Byarugaba, C. M. Ndugwa, A. Parkes, M. Ocaido, and J. K. Tumwine, “An up-date on the prevalence of sickle cell trait in Eastern and Western Uganda,” BMC Blood Disorders, vol. 10, article 5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Nwogoh, A. S. Adewoyin, O. E. Iheanacho, and G. N. Bazuaye, “Prevalence of haemoglobin variants in Benin City, Nigeria,” Annals of Biomedical Sciences, vol. 11, no. 2, pp. 60–64, 2012. View at Google Scholar
  7. S. D. Grosse, I. Odame, H. K. Atrash, D. D. Amendah, F. B. Piel, and T. N. Williams, “Sickle cell disease in Africa: a neglected cause of early childhood mortality,” American Journal of Preventive Medicine, vol. 41, no. 6, supplement 4, pp. S398–S405, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Makani, T. N. Williams, and K. Marsh, “Sickle cell disease in Africa: burden and research priorities,” Annals of Tropical Medicine and Parasitology, vol. 101, no. 1, pp. 3–14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Brozovic and S. Davies, “Management of sickle cell disease,” Postgraduate Medical Journal, vol. 63, no. 742, pp. 605–609, 1987. View at Publisher · View at Google Scholar · View at Scopus
  10. “Sickle Cell Anaemia. Agenda item 11.4,” in Proceedings of the 59th World Health Assembly, Geneva, Switzerland, May 2006, http://www.who.int/gb/ebwha/pdf_files/WHA59-REC1/e/WHA59_2006_REC1-en.pdf.
  11. F. A. Olatona, K. A. Odeyemi, A. T. Onajole, and M. C. Asuzu, “Effects of health education on knowledge and attitude of youth corps members to sickle cell disease and its screening in Lagos State,” Journal of Community Medicine & Health Education, vol. 2, no. 7, article 163, 2012. View at Publisher · View at Google Scholar
  12. R. S. Owolabi, P. Alabi, D. Olusoji, S. Ajayi, T. Otu, and A. Ogundiran, “Knowledge and attitudes of secondary school students in Federal Capital Territory, Abuja, Nigeria towards sickle cell disease,” Nigerian Journal of Medicine, vol. 20, no. 4, pp. 479–485, 2011. View at Google Scholar · View at Scopus
  13. S. Abubakar, U. M. Lawan, M. S. Mijinyawa, S. I. Adeleke, and H. Sabiu, “Perceptions about sickle cell disease and its prevention among undergraduates of tertiary institutions in Kano State, Nigeria,” Nigerian Journal of Clinical Medicine, vol. 3, no. 1, 2010. View at Google Scholar
  14. G. N. Bazuaye and E. E. Olayemi, “Knowledge and attitude of senior secondary school students in Benin City Nigeria to sickle cell disease,” World Journal of Medical Sciences, vol. 4, no. 1, pp. 46–49, 2009. View at Google Scholar
  15. D. A. Adekanle and A. S. Adeyemi, “Prevention of Sickle cell disease by prenatal diagnosis-opinion of female health workers in Osogbo, South-Western Nigeria,” Ibom Medical Journal, vol. 2, no. 1, pp. 20–22, 1997. View at Google Scholar
  16. M. A. Durosinmi, A. I. Odebiyi, I. A. Adediran, N. O. Akinola, D. E. Adegorioye, and M. A. Okunade, “Acceptability of prenatal diagnosis of sickle cell anaemia (SCA) by female patients and parents of SCA patients in Nigeria,” Social Science & Medicine, vol. 41, no. 3, pp. 433–436, 1995. View at Publisher · View at Google Scholar
  17. N. Win, “Blood transfusion therapy for Haemoglobinopathies,” in Practical Management of Haemoglobinopathies, I. E. Okpala, Ed., pp. 99–106, Blackwell Publishing, 2004. View at Google Scholar
  18. G. R. Serjeant, “Chronic transfusion programmes in sickle cell disease: problem or panacea?” British Journal of Haematology, vol. 97, no. 2, pp. 253–255, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. M. F. Murphy, T. B. Wallington, P. Kelsey et al., “Guidelines for the clinical use of red cell transfusions,” British Journal of Haematology, vol. 113, no. 1, pp. 24–31, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Liumbruno, F. Bennardello, A. Lattanzio, P. Piccoli, and G. Rossetti, “Recommendations for the transfusion of red blood cells,” Blood Transfusion, vol. 7, no. 1, pp. 49–64, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Pendergrast, “Transfusion of Patients with Thalassemia and Sickle Cell Disease,” https://www.lhsc.on.ca/lab/bldbank/assets/LLSGSymposium11/Pendergrast%202011%5B1%5D.pdf.
  22. K. Natarajan, “Disorders of haemoglobin structure: sickle cell anaemia and related abnormalities,” in Williams Haematology, M. A. Lichtman, Ed., vol. 47, pp. 667–700, McGraw-Hill, 2006. View at Google Scholar
  23. S. Charache, “The treatment of sickle cell anemia,” Archives of Internal Medicine, vol. 133, no. 4, pp. 698–705, 1974. View at Publisher · View at Google Scholar · View at Scopus
  24. M. J. Telen, “Principles and problems of transfusion in sickle cell disease,” Seminars in Hematology, vol. 38, no. 4, pp. 315–323, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Koshy, L. Burd, D. Wallace, A. Moawad, and J. Baron, “Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study,” The New England Journal of Medicine, vol. 319, no. 22, pp. 1447–1452, 1988. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Laulan, J. F. Bernard, and P. Boivin, “Systematic blood transfusions in adult homozygous sicle-cell anaemia,” Presse Medicale, vol. 19, no. 17, pp. 785–789, 1990. View at Google Scholar · View at Scopus
  27. A. R. Cohen, M. B. Martin, J. H. Silber, H. C. Kim, K. Ohene-Frempong, and E. Schwartz, “A modified transfusion program for prevention of stroke in sickle cell disease,” Blood, vol. 79, no. 7, pp. 1657–1661, 1992. View at Google Scholar · View at Scopus
  28. M. T. Lee, S. Piomelli, S. Granger et al., “Stroke prevention Trial in Sickle Cell Anaemia (STOP): extended Follow up and final results,” Blood, vol. 108, no. 3, pp. 847–852, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. W. F. Rosse, M. Narla, L. D. Petz, and M. H. Steinberg, “New views of sickle cell disease pathophysiology and treatment,” in American Society of Haematology Education Book, vol. 2000, pp. 2–17, 2000. View at Publisher · View at Google Scholar
  30. D. C. Rees, T. N. Williams, and M. T. Gladwin, “Sickle-cell disease,” The Lancet, vol. 376, no. 9757, pp. 2018–2031, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. G. R. Serjeant, B. E. Serjeant, and P. F. Milner, “The irreversibly sickled cell; a determinant of haemolysis in sickle cell anaemia,” British Journal of Haematology, vol. 17, no. 6, pp. 527–533, 1969. View at Publisher · View at Google Scholar · View at Scopus
  32. W. M. Lande, D. L. Andrews, M. R. Clark et al., “The incidence of painful crisis in homozygous sickle cell disease: correlation with red cell deformability,” Blood, vol. 72, no. 6, 1988. View at Google Scholar · View at Scopus
  33. Z. Y. Aliyu, A. R. Tumblin, and G. J. Kato, “Current therapy of sickle cell disease,” Haematologica, vol. 91, no. 1, pp. 7–10, 2006. View at Google Scholar · View at Scopus
  34. A. S. Wayne, S. V. Kevy, and D. G. Nathan, “Transfusion management of sickle cell disease,” Blood, vol. 81, no. 5, pp. 1109–1123, 1993. View at Google Scholar · View at Scopus
  35. M. H. Steinberg, “Management of sickle cell disease,” The New England Journal of Medicine, vol. 340, no. 13, pp. 1021–1030, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. E. P. Vinchinsky, “Transfusion therapy in sickle cell disease,” http://sickle.bwh.harvard.edu/transfusion.html.
  37. R. Adams, V. McKie, F. Nichols et al., “The use of transcranial ultrasonography to predict stroke in sickle cell disease,” The New England Journal of Medicine, vol. 326, no. 9, pp. 605–610, 1992. View at Publisher · View at Google Scholar · View at Scopus
  38. R. J. Adams, V. C. McKie, L. Hsu et al., “Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography,” The New England Journal of Medicine, vol. 339, pp. 5–11, 1998. View at Google Scholar
  39. S. T. Miller, E. Wright, M. Abboud et al., “Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia,” Journal of Pediatrics, vol. 139, no. 6, pp. 785–789, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. Z. R. Rogers, “Review: clinical transfusion management in sickle cell disease,” Immunohematology, vol. 22, no. 3, pp. 126–131, 2006. View at Google Scholar · View at Scopus
  41. Sickle Cell Disease in Childhood, Standards and Guidelines for Cliinical Care, NHS Sickle Cell and Thalassaemia Screening Programme, London, UK, 2nd edition, 2010.
  42. H. H. Al-Saeed and A. H. Al-Salem, “Principles of blood transfusion in sickle cell anemia,” Saudi Medical Journal, vol. 23, no. 12, pp. 1443–1448, 2002. View at Google Scholar · View at Scopus
  43. Sickle cell society, Standards for the clinical care of adults with sickle cell disease in the United Kingdom, Chapter 6: Blood transfusion 2008.
  44. W. H. Zinkham, A. J. Seidler, and T. S. Kickler, “Variable degrees of suppression of hemoglobin S synthesis in subjects with hemoglobin SS disease on a long-term transfusion regimen,” Journal of Pediatrics, vol. 124, no. 2, pp. 215–219, 1994. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Qureshi, Red Cell Transfusion in Sickle Cell Disease, University Hospital of Leicester NHS Trust, 2010.
  46. B. A. Gwalam, M. M. Bowdo, A. I. Dutse, and A. Kaliya-Gwarzo, “Patterns of acute blood transfusion reactions in Kano, north-western Nigeria,” Nigerian Journal of Basic and Clinical Sciences, vol. 9, pp. 27–32, 2012. View at Google Scholar
  47. O. P. Arewa, N. O. Akinola, and L. Salawu, “Blood transfusion reactions: evaluation of 462 transfusions at a tertiary hospital in Nigeria,” African Journal of Medicine and Medical Sciences, vol. 38, no. 2, pp. 143–148, 2009. View at Google Scholar · View at Scopus
  48. J. O. Adewuyi, “Blood group serology,” in Companion to Practical Haematology, vol. 10, pp. 74–84, 2007. View at Google Scholar
  49. L. A. M. Bashawri, “Red cell alloimmunization in sickle-cell anaemia patients,” Eastern Mediterranean Health Journal, vol. 13, no. 5, pp. 1181–1189, 2007. View at Google Scholar · View at Scopus
  50. K. Yazdanbakhsh, R. E. Ware, and F. Noizat-Pirenne, “Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management,” Blood, vol. 120, no. 3, pp. 528–537, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. Mid-Atlantic Sickle Cell Disease Consortium (MASCC) Guidelines, “Chronic transfusion in children with sickle cell disease,” Sickle cell disease in children and adolescents: diagnosis, guidelines for comprehensive care and protocols for management of acute and chronic complications, 2001.
  52. I. A. Shulman, “Prophylactic phenotype matching of donors for the transfusion of nonalloimmunized patients with sickle cell disease,” Immunohematology, vol. 22, no. 3, pp. 101–102, 2006. View at Google Scholar · View at Scopus
  53. E. P. Vichinsky, A. Earles, R. A. Johnson, M. S. Hoag, A. Williams, and B. Lubin, “Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood,” The New England Journal of Medicine, vol. 322, no. 23, pp. 1617–1621, 1990. View at Publisher · View at Google Scholar · View at Scopus
  54. D. R. Ambruso, J. H. Githens, R. Alcorn et al., “Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy,” Transfusion, vol. 27, no. 1, pp. 94–98, 1987. View at Publisher · View at Google Scholar · View at Scopus
  55. E. P. Vichinsky, N. L. C. Luban, E. Wright et al., “Prospective RBC phenotype matching ina stroke-Prevention trial in sickle cell anemia: a multicenter transfusion trial,” Transfusion, vol. 41, no. 9, pp. 1086–1092, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. S. T. Chou, T. Jackson, S. Vege, K. Smith-Whitley, D. F. Friedman, and C. M. Westhoff, “High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors,” Blood, vol. 122, no. 6, pp. 1062–1071, 2013. View at Publisher · View at Google Scholar
  57. A. R. Cohen, G. R. Buchanan, M. Martin, and K. Ohene-Frempong, “Increased blood requirements during long-term transfusion therapy for sickle cell disease,” Journal of Pediatrics, vol. 118, no. 3, pp. 405–407, 1991. View at Publisher · View at Google Scholar · View at Scopus
  58. B. Otaigbe, “Prevalence of blood transfusion in sickle cell anaemia patients in South-South Nigeria: a two-year experience,” International Journal of Medicine and Medical Science Research, vol. 1, no. 1, pp. 13–18, 2013. View at Google Scholar
  59. O. Oniyangi, P. Ahmed, O. T. Otuneye et al., “Strokes in children with sickle cell disease at the National Hospital, Abuja, Nigeria,” Nigerian Journal of Paediatrics, vol. 40, no. 2, pp. 158–164, 2013. View at Google Scholar
  60. A. O. Emeribe, A. O. Ejele, E. E. Attai, and E. A. Usanga, “Blood donation and patterns of use in southeastern Nigeria,” Transfusion, vol. 33, no. 4, pp. 330–332, 1993. View at Publisher · View at Google Scholar · View at Scopus
  61. S. G. Ahmed, U. A. Ibrahim, and A. W. Hassan, “Adequacy and pattern of blood donations in North-eastern Nigeria: the implications for blood safety,” Annals of Tropical Medicine and Parasitology, vol. 101, no. 8, pp. 725–731, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. E. U. Ejeliogu, S. N. Okolo, S. D. Pam et al., “Is human immunodeficiency virus still transmissible through blood transfusion in children with Sickle cell anaemia in Jos, Nigeria?” British Journal of Medicine and Medical Research, vol. 4, no. 21, pp. 3912–3923, 2014. View at Publisher · View at Google Scholar
  63. A. I. Lagunju, B. J. Brown, and O. O. Sodeinde, “Chronic Blood transfusion for primary and secondary stroke prevention in Nigerian children with Sickle cell disease: a five year appraisal,” Pediatric Blood and Cancer, vol. 60, no. 12, pp. 1940–1945, 2013. View at Google Scholar
  64. K. W. Chan, “Haemopoeitic stem cell transplantation for sickle cell disease: more options and many unanswered questions,” Journal of Blood Disorders & Transfusion, vol. 4, p. e106, 2013. View at Publisher · View at Google Scholar
  65. M. J. Stuart and R. L. Nagel, “Sickle-cell disease,” The Lancet, vol. 364, no. 9442, pp. 1343–1360, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. M. H. Steinberg, “Hydroxyurea treatment for sickle cell disease.,” TheScientificWorldJournal, vol. 2, pp. 1706–1728, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. R. E. Ware and B. Aygun, “Advances in the use of hydroxyurea,” Hematology, pp. 62–69, 2009. View at Google Scholar · View at Scopus
  68. S. C. Davies and A. Gilmore, “The role of hydroxyurea in the management of sickle cell disease,” Blood Reviews, vol. 17, no. 2, pp. 99–109, 2003. View at Publisher · View at Google Scholar · View at Scopus